Facebook LinkedIn Twitter RSS Feeds April 5, 2016 at 12:00 AM EDT Back Regeneron and MedImmune Enter into Licensing Agreement for the Development of Antibody Drug Conjugates to Treat Cancer Regeneron PBD Press Release_FINAL.pdf 369.2 KB